Skip to main content
Icure Pharmaceutical Incorporation logo

Icure Pharmaceutical Incorporation — Investor Relations & Filings

Ticker · 175250 ISIN · KR7175250000 KO Manufacturing
Open in API
Filings indexed 317 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 175250

About Icure Pharmaceutical Incorporation

https://www.icure.co.kr/eng/

Icure Pharmaceutical Incorporation is a biopharmaceutical company that researches, develops, manufactures, and commercializes high-tech drug products. The company's core expertise lies in its Transdermal Drug Delivery System (TDDS) technology, which facilitates 'Cure & Care' solutions through the skin. Its portfolio includes both pharmaceutical products, such as NSAIDS patches, and cosmetic lines developed with a pharmaceutical and medical foundation. Icure focuses on creating innovative formulations and drug delivery systems to improve therapeutic outcomes and patient convenience.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for the company '아이큐어 주식회사' (Icure Pharmaceuticals & Cosmetics Incorporated) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial data, business operations, management discussions, and corporate governance information, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
횡령ㆍ배임혐의발생
Legal Proceedings Report Classification · 1% confidence The document is a formal regulatory disclosure regarding the occurrence of embezzlement and breach of trust by a former executive of the company (Icure). It details the nature of the charges, the amounts involved, and the company's response. This type of disclosure regarding legal proceedings and corporate misconduct falls under the category of Legal Proceedings Report (LTR).
2025-08-05 Korean
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
Delisting Announcement Classification · 1% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for a specific company due to a regulatory review ('상장적격성 실질심사 대상'). This is a standard regulatory announcement issued by an exchange or company regarding trading status, which does not fit into specific categories like financial reports or M&A, making it a regulatory filing.
2025-08-05 Korean
기타시장안내 (상장적격성 실질심사 관련 안내)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice from the Korea Exchange regarding a company's 'listing eligibility review' (상장적격성 실질심사) following an embezzlement/breach of trust disclosure. It is a regulatory announcement concerning market status and compliance, which does not fit into specific categories like financial reports or M&A, making it a standard regulatory filing.
2025-08-05 Korean
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
Delisting Announcement Classification · 1% confidence The document is a short notice from the stock exchange regarding the timeline for a 'listing eligibility review' (상장적격성 실질심사) for the company Icure. It is a regulatory announcement concerning the status of the company's listing and does not fit into specific categories like financial reports or M&A. As it is a regulatory notification regarding exchange procedures, it falls under the RNS category.
2025-08-05 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and a subsequent amendment (정정신고) to the terms of the conversion price adjustment. This type of filing is a standard regulatory disclosure in the Korean market (DART system) concerning capital structure changes and financing activities. Since it details the specific terms, interest rates, conversion rights, and collateral for a financing instrument, it falls under the 'Capital/Financing Update' category.
2025-07-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.